Profil
Alexander Pickett is the founder and the Managing Director of Juvenescence Ltd., a company founded in 2016.
He is currently working as a Director at Morphoceuticals, Inc.
Postes actifs de Alexander Pickett
Sociétés | Poste | Début |
---|---|---|
Juvenescence Ltd.
Juvenescence Ltd. Financial ConglomeratesFinance Juvenescence Ltd. engages in operation as an investment holding company which develops therapeutic products for human ageing and longevity. It provides drug development, new company creation, academic licensing, and biotech investment. The company was founded by James Mellon, Gregory H. Bailey, Declan Dooganin, Alexander Pickett, and Anthony Chow in October 2016 and is headquartered in Liverpool, the United Kingdom. | Fondateur | 01/01/2016 |
Morphoceuticals, Inc.
Morphoceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Morphoceuticals, Inc. is an American US-based biotech company that pioneers bioelectric approaches to access anatomical programming, which is a core component of our biological operating system. The company uses proprietary combinations of ion channel and gap junction modulators to induce limb regeneration, improve amputation stump health, promote organ regeneration, and treat channelopathies. | Directeur/Membre du Conseil | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Entreprise privées | 2 |
---|---|
Juvenescence Ltd.
Juvenescence Ltd. Financial ConglomeratesFinance Juvenescence Ltd. engages in operation as an investment holding company which develops therapeutic products for human ageing and longevity. It provides drug development, new company creation, academic licensing, and biotech investment. The company was founded by James Mellon, Gregory H. Bailey, Declan Dooganin, Alexander Pickett, and Anthony Chow in October 2016 and is headquartered in Liverpool, the United Kingdom. | Finance |
Morphoceuticals, Inc.
Morphoceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Morphoceuticals, Inc. is an American US-based biotech company that pioneers bioelectric approaches to access anatomical programming, which is a core component of our biological operating system. The company uses proprietary combinations of ion channel and gap junction modulators to induce limb regeneration, improve amputation stump health, promote organ regeneration, and treat channelopathies. | Commercial Services |